CCRB Logo

Trial History Detail on 2009-12-03

CUHK_CCT00040

2005-09-08

Prospective

Not applicable

Department of Ophthalmology & Visual Sciences, The Chinese University of Hong Kong

Nil

Nil

Miss Joyce Kung

3/F, Hong Kong Eye Hospital, 147K Argyle Street, Kowloon

27623134

email joycekung@cuhk.edu.hk

Department of Ophthalmology & Visual Sciences, The Chinese University of Hong Kong

Dr. Timothy Y.Y. Lai

3/F, Hong Kong Eye Hospital, 147K Argyle Street, Kowloon.

27623134

eyeclinic@cuhk.edu.hk

Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong

A randomized controlled trial on the safety and efficacy of a modified regimen of photodynamic therapy with verteporfin on acute central serous chorioretinopathy

A randomized controlled trial on the safety and efficacy of a modified regimen of photodynamic therapy with verteporfin on acute central serous chorioretinopathy

Nil

Hong Kong

Yes

2005-01-04

Eye Diseases

Procedure

Photodynamic therapy

12 months

Observation

Inclusion criteria: Aged 18 years or older
VA with Snellen equivalent of >/= 20/200
Greatest linear dimension of the entire lesion with ICG-A guidance must not exceed 5400 µm

Exclusion criteria: On exogenous corticosteroid Systemic diseases such as Cushing's disease or renal diseases of glomerulonephritis Pregnancy
Visual acuity worse than 20/200 in the affected eye
Myopia </= -6.00 diopters,
Presence of any choroidal neovascularization or other maculopathy
Tear (rip) of the retinal pigment epithelium
A history of laser photocoagulation Ocular surgery in the recent 3 months Any contraindication for the verteporfin infusion or fluorescein or ICG injection

18

None set

Both Male and Female

Interventional

Randomized

Placebo

Open label

Single group

2005-10-01

62

Complete

Complete absorption of subretinal fluid

electrophysiological results

No

2013-01-16


Yes

Type Access Document Published On  
No documents yet.
  • Page 1 of 1.